Has Mark Tuttle, MD received payments from drug or device companies?

Yes. Drug and device makers reported $95,159 in general payments to Mark Tuttle, MD across 111 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Tuttle, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Tuttle, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Tuttle, MD

Adult Reconstructive Orthopaedic Surgery · Denver, CONPI 1821029562

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $86,062 of the $95,159 with a category attached, or 90.4%. UOC USA Inc accounts for 96.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $53,195 and has fallen 98.2% since, to $979 in 2025.

$95,159in general payments, 2019–2025

Across 111 payments — averaging $857.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UOC USA Inc$92K
Molnlycke Health Care US, LLC$2K
Abbott$631
Johnson & Johnson$234
Stryker$183
Shockwave Medical, Inc$160
plus $757 from 11 others

$110,000in ownership & investment interests, 2019–2025

Across 4 payments — averaging $27,500 each. An ownership or investment interest held by the physician or an immediate family member.

Valencia Technologies Corporation$110K

What the payments were for

Consulting fees$86,06290%
Travel & lodging$3,9754%
Food & beverage$5,1225%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UOC USA Inc	67	$91,585
Molnlycke Health Care US, LLC	4	$1,609
Abbott	12	$631
Johnson & Johnson	4	$234
Stryker	4	$183
Shockwave Medical, Inc	1	$160
Smith+Nephew	2	$144
Illuminoss Medical, Inc.	3	$139
Zimmer Biomet	2	$121
Pacira Therapeutics, Inc.	4	$97
Wound Management Technologies, Inc	1	$86
Kuros Biosciences USA, Inc	1	$42
Cardiovascular Systems Inc.	2	$40
Next Science LLC	1	$33
Acell, Inc.	1	$22
E.r. Squibb & Sons, L.L.C.	1	$20
Theragen, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

U-Star II$34,896
Pressfit$27,374
U2 Press-fit$5,790
Press Fit Knee$4,834
USTAR II$3,476
U2 Pressfit$2,833
N/A$2,833
Cone$2,575
CONFORMITY$1,854
U-Star II, U2, Conformity$1,500
U2 PF+$865
AMPLATZER AMULET$410
Cones$258
USTAR, PSA, and Conformity$210
U2 Press-fit and PSI$171
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$160
Conformity, U-Star II, U-Motion II, U2$159
Conformity, U2 Press-fit, Cones and USTAR II$152
Mepilex Border Post Op$149
Mepilex Border Post Op AG$149

How this compares

$95,159 in reported general payments places this provider in the 85th percentile of 31 adult reconstructive orthopaedic surgery providers in Colorado.

See all adult reconstructive orthopaedic surgery providers in Colorado →

Medicare billing

Part B allowed, 2024

$1,229

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	28	$33

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Denver

Armodios HatzidakisDenver$1.4M
Jason JenningsDenver$45K
Hailee ReistDenver$27K
Brian LarkinDenver$5K
Ryan CaufieldDenver$5K
James HolmesDenver$328
Sean GreyFort Collins$761K
Kirk KindsfaterFort Collins$578K
Derek JohnsonParker$181K
Michael DaytonAurora$56K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →